• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粪便钙卫蛋白在老年患者鉴别器质性炎症性胃肠疾病和功能性胃肠疾病中的诊断准确性

Diagnostic Accuracy of Fecal Calprotectin in Discriminating Organic-Inflammatory Gastrointestinal Diseases and Functional Gastrointestinal Disorders in Older Patients.

作者信息

Gallo Antonella, Covino Marcello, Baroni Silvia, Camilli Sara, Ibba Francesca, Andaloro Silvia, Agnitelli Maria Chiara, Rognoni Fiammetta Maria, Landi Francesco, Montalto Massimo

机构信息

Department of Geriatrics, Orthopedics and Rheumatology, Fondazione Policlinico Universitario "A. Gemelli", IRCCS, 00168 Rome, Italy.

Department of Emergency Medicine, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

出版信息

J Pers Med. 2024 Feb 21;14(3):227. doi: 10.3390/jpm14030227.

DOI:10.3390/jpm14030227
PMID:38540970
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10971633/
Abstract

Fecal calprotectin (FC) has been largely recognized as a surrogate marker of intestinal neutrophilic inflammation, very reliable in distinguishing between inflammatory bowel diseases and functional gastrointestinal (GI) disorders. Aging has been suggested to influence FC results and their diagnostic accuracy; however, no studies are specifically targeted on this focus. In a retrospective study, we evaluated the eventual age-differences of the diagnostic accuracy of FC in discriminating between organic-inflammatory GI diseases and functional GI disorders. In 573 younger and 172 older (≥65 years) subjects undergoing an FC assay, we found that the latter showed higher median FC values, 72 (25-260) µg/g vs. 47 (25-165) µg/g ( < 0.01). Younger patients were more commonly affected by IBDs, while colorectal cancer and high-risk polyps, infective colitis, and diverticular disease represented the most common findings in the older subgroup. However, the estimated optimum FC threshold in discriminating between organic-inflammatory GI diseases and functional GI disorders was quite similar between the two groups (109 μg/g for the younger subgroup and 98 μg/g for the older subgroup), maintaining a very high specificity. In conclusion, we show that FC also represents a very specific test for intestinal inflammation in older patients, at similar threshold levels to younger subjects.

摘要

粪便钙卫蛋白(FC)已被广泛认为是肠道中性粒细胞炎症的替代标志物,在区分炎症性肠病和功能性胃肠(GI)疾病方面非常可靠。有研究表明衰老会影响FC结果及其诊断准确性;然而,尚无专门针对此重点的研究。在一项回顾性研究中,我们评估了FC在区分器质性炎症性胃肠疾病和功能性胃肠疾病时诊断准确性的年龄差异。在573名年轻受试者和172名老年(≥65岁)受试者中进行了FC检测,我们发现老年受试者的FC中位数较高,分别为72(25 - 260)μg/g和47(25 - 165)μg/g(P < 0.01)。年轻患者更常患炎症性肠病,而老年亚组中最常见的疾病是结直肠癌、高危息肉、感染性结肠炎和憩室病。然而,两组在区分器质性炎症性胃肠疾病和功能性胃肠疾病时,估计的最佳FC阈值相当相似(年轻亚组为109μg/g,老年亚组为98μg/g),特异性均很高。总之,我们表明FC对老年患者的肠道炎症也是一种非常特异的检测方法,其阈值水平与年轻受试者相似。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/e162e2a4a15b/jpm-14-00227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/3cc8cd6f3b9a/jpm-14-00227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/cc871761ecc4/jpm-14-00227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/e162e2a4a15b/jpm-14-00227-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/3cc8cd6f3b9a/jpm-14-00227-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/cc871761ecc4/jpm-14-00227-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2692/10971633/e162e2a4a15b/jpm-14-00227-g003.jpg

相似文献

1
Diagnostic Accuracy of Fecal Calprotectin in Discriminating Organic-Inflammatory Gastrointestinal Diseases and Functional Gastrointestinal Disorders in Older Patients.粪便钙卫蛋白在老年患者鉴别器质性炎症性胃肠疾病和功能性胃肠疾病中的诊断准确性
J Pers Med. 2024 Feb 21;14(3):227. doi: 10.3390/jpm14030227.
2
Faecal calprotectin, an useful marker in discriminating between inflammatory bowel disease and functional gastrointestinal disorders.粪便钙卫蛋白是区分炎症性肠病和功能性胃肠疾病的有用标志物。
Gastroenterol Hepatol. 2017 Mar;40(3):125-131. doi: 10.1016/j.gastrohep.2016.04.009. Epub 2016 May 31.
3
Clinical utility and diagnostic accuracy of faecal calprotectin for IBD at first presentation to gastroenterology services in adults aged 16-50 years.粪便钙卫蛋白在16至50岁成人首次就诊于胃肠病科时对炎症性肠病的临床实用性及诊断准确性
J Crohns Colitis. 2015 Jan;9(1):41-9. doi: 10.1016/j.crohns.2014.07.005.
4
Fecal calprotectin is an effective diagnostic tool that differentiates inflammatory from functional intestinal disorders.粪便钙卫蛋白是一种有效的诊断工具,可区分炎症性肠病和功能性肠病。
Scand J Gastroenterol. 2014 Dec;49(12):1419-24. doi: 10.3109/00365521.2014.934913. Epub 2014 Nov 5.
5
Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.新型 LIAISON 粪便钙卫蛋白检测对炎症性肠病与肠易激综合征鉴别诊断的临床性能。
J Clin Gastroenterol. 2021 Mar 1;55(3):239-243. doi: 10.1097/MCG.0000000000001359.
6
Clinical utility of fecal calprotectin: potential applications beyond inflammatory bowel disease for the primary care physician.粪便钙卫蛋白的临床应用:基层医疗医生在炎症性肠病之外的潜在应用
Ann Gastroenterol. 2019 Sep-Oct;32(5):425-430. doi: 10.20524/aog.2019.0394. Epub 2019 Jun 20.
7
Elevated levels of faecal calprotectin in primary Sjögren's syndrome is common and associated with concomitant organic gastrointestinal disease.原发性干燥综合征患者粪便钙卫蛋白水平升高很常见,且与合并的器质性胃肠疾病有关。
Arthritis Res Ther. 2016 Jan 12;18:9. doi: 10.1186/s13075-015-0907-8.
8
Effectiveness and cost-effectiveness of measuring fecal calprotectin in diagnosis of inflammatory bowel disease in adults and children.粪便钙卫蛋白检测对成人和儿童炎症性肠病诊断的有效性和成本效益。
Clin Gastroenterol Hepatol. 2014 Feb;12(2):253-62.e2. doi: 10.1016/j.cgh.2013.06.028. Epub 2013 Jul 21.
9
Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases.粪便钙卫蛋白在预测重大胃肠道疾病中的诊断准确性。
JGH Open. 2021 May 6;5(6):647-652. doi: 10.1002/jgh3.12548. eCollection 2021 Jun.
10
FECAL CALPROTECTIN: levels for the ethiological diagnosis in Brazilian patients with gastrointestinal symptoms.粪便钙卫蛋白:巴西胃肠道症状患者病因诊断的水平
Arq Gastroenterol. 2015 Jan-Mar;52(1):50-4. doi: 10.1590/S0004-28032015000100011.

本文引用的文献

1
Fecal Calprotectin and Organic Gastrointestinal Disease: A Systematic Review.粪便钙卫蛋白与器质性胃肠疾病:一项系统综述
Cureus. 2023 Sep 11;15(9):e45019. doi: 10.7759/cureus.45019. eCollection 2023 Sep.
2
Systematic review with meta-analysis: Diagnostic performance of faecal calprotectin in distinguishing inflammatory bowel disease from irritable bowel syndrome in adults.系统评价与荟萃分析:粪便钙卫蛋白鉴别成人炎症性肠病与肠易激综合征的诊断性能。
Aliment Pharmacol Ther. 2023 Dec;58(11-12):1120-1131. doi: 10.1111/apt.17754. Epub 2023 Oct 12.
3
Symptomatic Uncomplicated Diverticular Disease (SUDD): Practical Guidance and Challenges for Clinical Management.
症状性单纯性憩室病(SUDD):临床管理的实用指南与挑战
Clin Exp Gastroenterol. 2023 Mar 28;16:29-43. doi: 10.2147/CEG.S340929. eCollection 2023.
4
The usefulness of fecal hemoglobin and calprotectin tests in diagnosing significant bowel diseases: a prospective study.粪便血红蛋白和钙卫蛋白检测在诊断显著肠道疾病中的作用:一项前瞻性研究。
Scand J Gastroenterol. 2023 Apr;58(4):368-374. doi: 10.1080/00365521.2022.2133551. Epub 2022 Oct 19.
5
Fecal Calprotectin in Parkinson's Disease and Multiple System Atrophy.帕金森病和多系统萎缩中的粪便钙卫蛋白
J Mov Disord. 2022 May;15(2):106-114. doi: 10.14802/jmd.21085. Epub 2021 Dec 24.
6
Diagnostic accuracy of fecal calprotectin in predicting significant gastrointestinal diseases.粪便钙卫蛋白在预测重大胃肠道疾病中的诊断准确性。
JGH Open. 2021 May 6;5(6):647-652. doi: 10.1002/jgh3.12548. eCollection 2021 Jun.
7
ACG Clinical Guideline: Management of Irritable Bowel Syndrome.ACG 临床指南:肠易激综合征的管理。
Am J Gastroenterol. 2021 Jan 1;116(1):17-44. doi: 10.14309/ajg.0000000000001036.
8
Functional gastrointestinal disorders: advances in understanding and management.功能性胃肠病:理解和治疗方面的进展。
Lancet. 2020 Nov 21;396(10263):1664-1674. doi: 10.1016/S0140-6736(20)32115-2. Epub 2020 Oct 10.
9
Gut Microbiota and Dysbiosis in Alzheimer's Disease: Implications for Pathogenesis and Treatment.阿尔茨海默病中的肠道微生物群与生态失调:对发病机制和治疗的影响
Mol Neurobiol. 2020 Dec;57(12):5026-5043. doi: 10.1007/s12035-020-02073-3. Epub 2020 Aug 23.
10
Clinical Performance of a Novel LIAISON Fecal Calprotectin Assay for Differentiation of Inflammatory Bowel Disease From Irritable Bowel Syndrome.新型 LIAISON 粪便钙卫蛋白检测对炎症性肠病与肠易激综合征鉴别诊断的临床性能。
J Clin Gastroenterol. 2021 Mar 1;55(3):239-243. doi: 10.1097/MCG.0000000000001359.